Gene · 1633
Papers2,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| High-Throughput CRISPR Screening in Hematological Neoplasms. | Cancers (Basel) | 2022 | 35892871 | PubTator, text mining | PubMed |
| Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism. | Int J Mol Sci | 2022 | 35887170 | PubTator, text mining | PubMed |
| β-Hydroxyisovaleryl-Shikonin Exerts an Antitumor Effect on Pancreatic Cancer Through the PI3K/AKT Signaling Pathway. | Front Oncol | 2022 | 35860565 | PubTator, text mining | PubMed |
| Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases. | Acta Pharm Sin B | 2022 | 35847511 | PubTator, text mining | PubMed |
| Targeting Ferroptosis Pathway to Combat Therapy Resistance and Metastasis of Cancer. | Front Pharmacol | 2022 | 35847022 | PubTator, text mining | PubMed |
| Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer. | J Clin Lab Anal | 2022 | 35837987 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. | Drug Deliv | 2022 | 35815678 | PubTator, text mining | PubMed |
| Prognostic models for outcome prediction in patients with advanced hepatocellular carcinoma treated by systemic therapy: a systematic review and critical appraisal. | BMC Cancer | 2022 | 35810271 | PubTator, text mining | PubMed |
| Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer. | Cancers (Basel) | 2022 | 35804923 | PubTator, text mining | PubMed |
| Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective. | Cancers (Basel) | 2022 | 35804885 | PubTator, text mining | PubMed |
| Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach. | Cancer Drug Resist | 2022 | 35800364 | PubTator, text mining | PubMed |
| Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives. | J Adv Res | 2022 | 35777908 | PubTator, text mining | PubMed |
| Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing. | Nat Commun | 2022 | 35773273 | PubTator, text mining | PubMed |
| Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. | J Hematol Oncol | 2022 | 35765040 | PubTator, text mining | PubMed |
| Stem Cell Biomarkers and Tumorigenesis in Gastric Cancer. | J Pers Med | 2022 | 35743714 | PubTator, text mining | PubMed |
| Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present. | Biomolecules | 2022 | 35740940 | PubTator, text mining | PubMed |
| Breaching Brain Barriers: B Cell Migration in Multiple Sclerosis. | Biomolecules | 2022 | 35740925 | PubTator, text mining | PubMed |
| PARP Inhibitors: A New Horizon for Patients with Prostate Cancer. | Biomedicines | 2022 | 35740437 | PubTator, text mining | PubMed |
| Most mitochondrial dGTP is tightly bound to respiratory complex I through the NDUFA10 subunit. | Commun Biol | 2022 | 35739187 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1633/papers?page=16